CLINICAL_TRIALS
trial_result
· 2015-06-12
Clinical Trial Update: MK0767 Glipizide Comparator Cardiac Safety Study (0767-018) [Phase 3]
Summary
Phase 3 trial comparing MK0767 to glipizide for cardiac safety in type 2 diabetes was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED